Rang	Name	Position
1	Dr. Michael E. Castagna Pharm.D.	CEO & Director
2	Mr. Christopher B. Prentiss M.B.A.	Chief Financial Officer
3	Dr. David B. Thomson J.D., Ph.D.	Executive VP, General Counsel & Secretary
4	Dr. Stuart A. Tross Ph.D.	Chief People & Workplace Officer
5	Mr. Dominic Marasco R.Ph.	President of Endocrine Business Unit
6	Mr. Sanjay Singh M.B.A.	Executive Vice President of Technical Operations
7	Dr. Ajay Ahuja M.B.A., M.D.	Executive VP & Chief Medical Officer
8	Dr. Wassim Fares M.D., M.Sc.	Senior VP and Therapeutic Area Head of Respiratory & (interim) Cariorenal

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	9,99%	0,11 Mrd. USD
2	Rubric Capital Management LP	5,60%	0,06 Mrd. USD
3	State Street Corp	5,03%	0,05 Mrd. USD
4	Vanguard Capital Management, LLC	4,10%	0,04 Mrd. USD
5	Geode Capital Management, LLC	2,47%	0,03 Mrd. USD
6	Wellington Management Company LLP	2,44%	0,03 Mrd. USD
7	Frazier Life Sciences Management, L.P.	2,05%	0,02 Mrd. USD
8	Deep Track Capital, LP	1,87%	0,02 Mrd. USD
9	180 WEALTH ADVISORS, LLC	1,54%	0,02 Mrd. USD
10	FMR Inc	1,28%	0,01 Mrd. USD
11	TSP Capital Management Group/LLC	1,24%	0,01 Mrd. USD
12	AQR Capital Management LLC	1,18%	0,01 Mrd. USD
13	Morgan Stanley - Brokerage Accounts	1,08%	0,01 Mrd. USD
14	BRAIDWELL LP	1,08%	0,01 Mrd. USD
15	Vanguard Portfolio Management, LLC	0,93%	0,01 Mrd. USD
16	Northern Trust Corp	0,90%	0,01 Mrd. USD
17	UBS Group AG	0,90%	0,01 Mrd. USD
18	Two Sigma Investments LLC	0,84%	0,01 Mrd. USD
19	Charles Schwab Investment Management Inc	0,81%	0,01 Mrd. USD
20	Bank of America Corp	0,74%	0,01 Mrd. USD